Related Experiment Videos
Maternal arrhythmias during pregnancy
Simone Ferrero1, Barbara Maria Colombo, Nicola Ragni
1Dipartimento di Ostetricia e Ginecologia, Università degli Studi di Genova, Padiglione 1 Ospedale San Martino, Largo Rosanna Benzi, 16132 Genoa, Italy. simoneferrero@libero.it
Archives of Gynecology and Obstetrics
|June 29, 2004
Summary
Pregnancy can cause maternal cardiac arrhythmias, but most can be effectively managed with treatments similar to non-pregnant patients. Careful drug selection and consideration of fetal risks ensure safe and successful outcomes for pregnant individuals experiencing arrhythmias.
Area of Science:
- Cardiology
- Maternal-Fetal Medicine
- Pharmacology
Background:
- Pregnancy is associated with an increased incidence of maternal cardiac arrhythmias.
- These arrhythmias can range from mild premature beats to severe supraventricular and ventricular tachycardias.
Purpose of the Study:
- To review the management of cardiac arrhythmias during pregnancy.
- To highlight considerations for antiarrhythmic drug selection and treatment efficacy.
Main Methods:
- Review of current literature on managing arrhythmias in pregnant patients.
- Analysis of safety and efficacy data for antiarrhythmic drugs during pregnancy.
- Evaluation of non-pharmacological interventions like cardioversion.
Main Results:
- Management strategies for arrhythmias in pregnancy are largely similar to non-pregnant patients.
- Key considerations include fetal safety, teratogenicity, and effects on labor, delivery, and lactation.
- Certain antiarrhythmic drugs (e.g., propranolol, metoprolol, digoxin, quinidine) have demonstrated safety and efficacy.
- Intravenous adenosine is effective for supraventricular tachycardia when vagal maneuvers fail.
- Drug therapy is preferably avoided in the first trimester.
- Direct current cardioversion is an option for hemodynamically unstable patients when drug therapy fails or is contraindicated.
Conclusions:
- Most cardiac arrhythmias during pregnancy can be successfully treated.
- Individualized antiarrhythmic drug selection based on the specific arrhythmia and maternal cardiac condition is crucial.
- While no drug is entirely risk-free, many antiarrhythmic agents can be used with relatively low risk during pregnancy.